Diginex Strengthens Supply Chain Product Suite Amid Regulatory Pressure

Diginex Limited has announced the expansion of its end-to-end supply chain solution, Risk-to-Remedy. This move comes amid escalating regulatory demands, particularly as the market for human rights and supply chain due diligence is expected to grow from $3.8 billion in 2025 to $9.6 billion by 2034. This expansion aims to support businesses in meeting stringent transparency and compliance requirements.

Risk-to-Remedy combines risk assessment, direct worker engagement, and grievance mechanisms to close gaps between corporate declarations and demonstrable actions. With increased scrutiny due to regulations like the UK and Australia's Modern Slavery Acts, companies face financial and reputational risks without adequate compliance.

Diginex’s upcoming enhancements will help businesses efficiently manage assessments, audits, and evidence collection. These tools will be crucial as supply chain due diligence becomes a strategic necessity, combining technology with transparency to foster responsible sourcing.